Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

Overview of attention for article published in Journal of Medical Case Reports, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 4 X users, with an upper bound of 4,280 followers.

RT @jmedcasereports: Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a B…

19 Aug 2021

Reply Repost Favourite

Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier https://t.co/q7QoGBo0QE https://t.co/nw9y5hTTMO

19 Aug 2021

Reply Repost Favourite

Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report https://t.co/Vo7ceytZeD

23 Apr 2021

Reply Repost Favourite

Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report https://t.co/8KKlntedwh

23 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.